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Cytotoxic action of various prostag landins (PGs) was ex-
amined on the PAM 212 transform ed mouse epidermal ce ll 
line, and ,:l7-PGA , was found most active. ,:l7-PGA , exerted 
a dose-dependent inhibition of PAM 2] 2 cell growth o)ler 
0. 1 fLg/ml (0.3 fLM). At 1.6 fLg/ml (4.6 fLM ) g rowth was 
completely inhibited , and the number of viable cell s de-
creased remarkably during culture. T he concentration needed 
for 50% g rowth inhibition (ICso) va lue of ,:l7-PGA , on 
PAM 212 cell growth was calculated as 0.4 fLg/ ml (1.1 
fLM). At this concentration, the DNA synthesis in 24- and 
48-h cultured cell s was decreased to a half of the level in 
the control cell s, and microscopicall y, remaining cells showed 
degenerative changes with many vacuoles in their cy to-
plasm. 
Prostag landin O 2, a m ajor PG in mas t cells, also showed 
potent cytotoxic acti vity. However, this action was ex-
T he prostag landin (PG) represents one o f the mos t im-port:lI1t naturall y occurrin g compo unds exhibiting substantial biolog ic activity, and ma y play an im-po rtant role 111 acute IIlflammatl on because of th eir vasodil ator properties and beca use of th eir ca pacity 
to ma gnify the ex udative effects [1-3] . The role of the PGs in 
cutaneous infl ammatio n has been ca refull y studied using sunburn 
ultraviolet (UV) ery thema as a m odel [4-61. In a previous stud y, 
we showed th at the amount of PGD2, determin ed by a specifi c 
radioimmunoassay, was eleva ted 3 h after UVB irradiat ion in 
mouse skin (7, 8]. The PGs are also impo rtant in the mod ul ation 
of immediate and dela yed immunologic reacti on 19J. Recently, 
so m e kinds of PGs have been dem onstrated to inhibit cell pro-
liferatio n in var io us cell lines in v itro [1 0, 11] and in vivo [1 2]. In 
this paper, we examined th e cyto tox ic effect o f various PGs o n 
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Abbreviations: 
DMEM: Du lbecco's m odified Eagle 's Ill edi ulll 
FCS: feta l ca lf se rum 
IC su: concentration needed for 50% growth inhibition 
PG: prostaglandin 
pressed as 9-deoxy-,:l'J· '2-]3,14-dihydro-PGD 2 (,:l12_PG]2), 
w hich was converted from PGD2 in plasma, and had a 3-
fo ld stron ger growth inhibitory activity than PGD2; the 
ICso va lues of PGD2 and ,:l1 2_PG]Z were 2 fLg/ml (5.7 fLM ) 
and 0.75 fLg/ ml (2.] fLM), respectively. Among other PGs 
tested, PGA2 showed a co mparable growth inhibitory ac-
tivity, and PGB 2, PGE
" 
and PGE2 less but significant ac-
tivity. Prostaglandin F Z<r and PGlz however, had no such 
effect on cell proliferation at 5 fLg/ml (14.3 fLM ) concen-
tration, sugges ting that cyclopentenone stru cture is an es-
sential moiety ofPG derivatives for cell growth inhibition. 
This cy totoxic action of ,:l7-PGA 1 and ,:l1 2_PG]2 appears to 
be independent of cyclic-AMP, sin ce these PGs were vir-
tuall y inactive in raising intracellular cycl ic-AMP levels in 
PAM 212 cell s. J Ill vest Dermato! 89:69- 72, 1987 
the proliferatio n of a transformed mouse epiderm al cell line (PAM 
212 cells) [1 3]. 
MATE RIALS AND METHODS 
Chemicals Synthetic PGs, 6,7-PGA h PGA2, PGB2, PGD2, PGE h 
PGE2, PGF2,., PG I2, and 6,1 2_PGJ2 we re genero us g ifts from Ono 
Pharm aceutical Co. Ltd ., Osaka , Japan. [3H]Thym idine (21 
C i/ mmol) was purchased fro m the Rad iochemi cal Centre, Amer-
sham, E ngland. Cyclic-AMP rad io immunoassay kit was pur-
chased from Yamasa Shoyu Ltd. , C hoshi , Japan. Fetal ca lf serum 
(FCS) was fro m GIBCO G rand Island , New York. All other 
chemi cals we re of anal ytica l g rade. 
Cell Culture The transform ed keratinocyte cell line PAM 212, 
derived o rig inall y fro m a newbo rn BALBlc m o use, was obtained 
from S. H . Yuspa (Labo ratory of Ex perim ental Patho logy, N a-
tionallnstirutes o f H ealth , Bethesda, Maryland). Its characteristics 
and in vitro maintenan ce have been des cribed previo usly [13,14]. 
Cell s were cultured in Dulbecco's m od ified Eagle's m edium 
(D M EM) supplemented wi th 15% FCS . Prostag landins were dis-
solved in 99.5% ethanol and diluted in culture medium imme-
diatel y before usc, with a fina l concentration o f 0.1 % ethanol as 
described prev io usly [1 5]. Contro l m ed ia contained 0. 1 % ethano l. 
PAM 212 cells were plated Jt a density of 0.2 x 105 cells/ ml in 
5 ml o f media and in cubated at 37°C in 5% CO2. After incubation , 
th e attached cells were remo ved by trypsini za tion , and cell v ia-
bility was measured by try pan blue exclusion at the tim es indi-
ca ted . 
Measurement of ON A Synthesis PAM 212 cells (1 05 cells/5 
1111 med ium), which were trypsinized and suspended in DMEM 
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Table I. Comparison of Prostaglandins for PAM 212 Cell 
Growth Inhibition 
Cel l Number 
Addition ( x 10" cel ls/dish)" p Value 
None 50.0 ± 5.3 
~7_PGA, 0.8 ± 0.2 P < 0.00 1 
PGA2 4.3 ± 0.6 p < 0.001 
PGB2 33.8 ± 1.7 p < 0.02 
PGD2 3.8 ± 0.9 p < 0.001 
PGE, 40.5 ± 3.5 p < 0.1 
PGE2 33.3 ± 3.3 p < 0.02 
PGF2u 49.1 ± 3. 1 NS1, 
PGIo 47.0 ± 1.8 NS1• 
t,' 2_PGJ2 1.3 ± 0.2 p < 0.001 
"PAM 2 12 cells (10' cells/d ish) were dispersed. 3nd simLlIt3n coLl sly 5 iLg/ ml of 
V3 ri oLls prostaglandins were added. After 48 h. the number of viable cells was 
cou nted as described in Mal c";a(s m,d Methods. The values represent m ea ns of3 dishes 
:!: SO. 
"Not signi ficant. 
supplem ented with 15% FCS, were dispersed and simultaneously 
0.4 or 0 .8 /Lg/ml ~7-PGAI was added. After 24, 48, and 72 h, 
cells were incubated in DMEM containing 15% FCS for 4 h with 
10 /LCi of (3H]thymidine at 37°C in 5% CO2. Following the 
labeling, the m edium was discarded and cultures were washed 
twice with saline. Tbe radioactivity in corporated into acid-in-
soluble m aterials w as counted as described previously [15] . Bio-
synth esis of DNA was expressed in terms ofl X 105 vi able cells. 
Measurement of Cyclic-AMP Content Forty-eight hours after 
plating , dish es w ere preincubated in Dulbecco 's phosphate-buff-
ered sa line at 37°C for 15 min. The reaction w as started by adding 
PGs, ca rried Ollt at 3rC for 5 min, and terminated by the additi on 
of trichloroaceti c acid to the fin al concentration of 6%. Cyclic-
AMP contents in acid extracts w ere m eas ured by radio immu-
noassay as described (16]. 
Statistical Analysis Student's I-tes t was employed to determine 
the statistical difference between m eans. 
RESULTS 
Comparison of PGs for PAM 212 Cell Growth Inhibition 
G rowth inhibitory activities of various PGs after 48 h of ,'jlture 
were compared on PAM 212 cells (Table I) . Amon g these PGs , 
~7-PGAI ' one of the synthesized alkylidenecyclopentenone PG 
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Figure 1. Dose response curve of PGs. PAM 212 cells were cultured in 
the presence of various concentrations of t,7-PGA I' t,1 2_PGJ2' or PGD2 
as described under Materials alld Methods. After 3 days' culture, the attached 
cells were removed by trypsinization and the number of cells that excluded 
try pan blue was counted. In this experim ent, 100% represent cell numbers 
of approximatel y 2 x 105 cells/ml medium: ~7_PGA, (solid circles), t, 12_ 
PGJ2 (opell circles), PGD2 (so lid Irinllgles). 
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Figure 2. Cultures of PAM 212 cells in vitro . Cells in each dish were 
exposed for 3 days to 0.4 /-Lg/ ml ~7_PGA, (leji) or ethanol control (right). 
x 200. 
derivatives [17], was found most active, and PGA2, PGD2, and 
~1 2_PGJ2 showed a potent cy totoxic activity on transformed mouse 
epidermal cells in culture as already reported with other cell lines 
[15]. Prostaglandin B2, PGE1, and PGE2 showed a less but sig-
nifi cant growth inhibitory activity. On the other hand , PGF2a 
and PGlz had no effects under the present conditions. When PGlz 
or PGF2" were ad ded simultaneously with ~7-PGAI 'o r ~I Z_PGJz 
in the same am o unts, no change was found in the growth inhi-
bition of PAM 212 cells, suggesting that neither PGlz no r PGF2" 
interfered w ith the action of ~7_PGAI or ~1 2_PGJ2 at the cellular 
level (data no t shown). 
Effect of Cytotoxic PGs on Proliferation of PAM 212 Cells 
Wh en PAM 212 cell s were g rown with various concentrations of 
~7-PGAI ' ~1 2_ PGJ2' o r PGD2 for 3 days, a dose-depend ent in-
hibiti on of g rowth was observed over 0.1 /Lg/ml (Fig 1). The 
IC so va lue (concentration needed fo r 50% g rowth inhibition) of 
~7_PGAI was ca lculated to be O.4/Lg/ml under the conditions we 
exa min ed. Over 0.4 /Lg/ml of ~7-PGAI' cells showed degener-
ative changes microscopically with m any vacuoles in their cy-
toplas m (Fig 2). Ex posure to hig her co ncentrations of PGs (~7_ 
PGA I, g rea ter than 5 /Lg/ml) cau sed irreversible cell chan ges. 
Figure 3 shows th e gro wth curve of PAM 212 cell s in the presence 
of ~7_PGA I in a concentration of 0.4 o r 0.8/Lg/mlmedium. PAM 
212 cells g rew exponentiall y with a doublin g tim e of approxi-
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Figure 3. Growth curve of PAM 212 cells in the presence of t,7-PGA\. 
Cel ls were cultured as described under Materials mid Methods: with 0.8 
/-Lg/ml of ~7-PGA \ (opell circles), with 0.4 /-L g/ml of t,7-PGA, (so lid tri-
angles), control (solid circles). Each point' represents means of3 dishes ± SO. 
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Table II. Effect of ~7_PGA I on DNA Synthesis 
of PAM 212 Cells 
Culture Time 
o time 
24 h 
48 h 
72h 
o 
8526 ± 319 
3218 ± 157 
41 95 ± 216 
25 17 ± 125 
0.4 0.8 
ThYlllidill e (CplII / to" cells)" 
48 13 ± 196 2842 ± 153 
1541 ± 123 556 ± 93 
1923 ± 156 923 ± 51 
1318 ± 101 795 ± 48 
"PAM 2 12 cells (10; cell s/dish) were dispersed. and simu ltaneou sly 0.4 o r 0.8 
J.Lg/ ml o f t,7-PGA r was added. Arter 24. 48. 72 h. DNA synthesis was assayed as 
described undet Materials alld Me thods. The va lu es represent mea ns of 3 expeti men ts 
± SD. 
m ately 25 h by the 4th day, and then the growth rate decreased 
(data no t shown) . ~7-PGAI decreased the growth rate of PAM 
212 cells to a half of the level of the control cells at 0.4 ILg/ml. 
Effect of .;i7-PGA. on DNA Synthesis of PAM 212 Cells As 
illustrated in Table II , DNA synthesis was suppressed to 48% 
and 46% of the con trol level after 24- and 48-h culture w ith 0.4 
ILg/ml of ~7_PGA .. respectivel y. At 0 time, DNA synth esis is 
higher than at 24, 48, and 72 h, because the 0 time value represents 
almost complete anchorage-independent growth. 
Effect of Cytotoxic PGs on Cyclic-AMP Content in PAM 
212 Cells As illustrated in Table Ill , PGE1 and PGEz were the 
most potent stimulators of adenylate cyclase in PAM 212 cells. 
Both ~1 2_PGJ2 and ~7-PGA I were virtuall y inactive in raising 
cycl ic-AMP levels in these cells. On the o ther hand, PGE1 was 
several tim es less potent than ~ 12_PGJ2 on cell growth inhibition 
(Table I) . 
DISCUSSION 
This stud y revealed that PGs of the A, E, and 0 series ca used 
the inhibition of growth in transform ed epiderm al cells in cu lture 
and showed that ~7_PGAI w as most active among these PGs. 
The IC so value of ~7_PGAI o n PAM 212 cell g rowth was 0.4 
ILg/ml which was abou t 6 tim es less concentration than the IC so 
value of bleomycin (2.4 ILg/m l) under similar experimental con-
ditions . Similar cytotoxi c action of PGs was recently reported on 
various cell lines including m as tocytoma cultured cells [1 8], hu-
man os teosa rco ma cells [1 0], and B-16 mo use melano ma cells 
[1 0, 11]. Stringfellow and Fitzpatrick reported an antimetasta ti c 
action ofPGD2 on B-16 melanoma cells in vivo [1 2], which they 
ascribed to th e inhibition of platelet aggrega tion. However, in 
view of the cytotoxic action and the relatively weak ant iaggre-
gatory activity of PGD2 on rodent platelets [1 9], the direct growth 
inhibition by PGD2 in vivo might also contribute to such pre-
Table III. Effect of Prostaglandins on Cyclic-AMP Content 
of PAM 212 Cells 
Cyclic-AMP 
Addition J.LM (pmolll05 cell s)" p Value 
Control .10.7 ± 1.4 
PGE1 1" 19.6 ± 2.0 P < 0.0 1 
PGE1 10 20.0 ± 2.4 p < 0.01 
PGEz 10 22.8 ± 2.7 p < 0.005 
PGFza 10 11.4 ± 1. 7 NS' 
t,1 2_PGJ2 10 10.8 ± 1.5 NS' 
t,7-PGA r 10 11. 2 ± 1. 3 NS' 
' PAM 2 12 cell s (5 X lOS cell s/dish) were in cubated with vatiolls prostag landins 
at 37°C (o r 5 min. Extraction and determinatio n of cycli c-AM P were performed 35 
described undet Materials alld Meth ods. T he va lues represen t mean s of 3 dishes ± 
SD. 
' One J.LM of pros taglandins is approximately 0.35 J.Lg/ml. 
"Not significant . 
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vention. Prostag landin E and PGD are enzy mati call y dehydrated 
in the presence of plasma or serum to form cyclopentenone PGs, 
nam ely PGA and ~1 2-PGh [20-22]. N arumiya and Fukushima 
have shown th at the growth inhibitory ac tivity ofPGDz is actually 
exerted by the dehydration product, and PGDz serves onl y as a 
precurso r of the active compound [23]. T he authors also o bserved 
this result in PAM 212 cells. N o significant g row th inhibition 
was found w hen the medium contain ing PGD2 was changed every 
6 h during the 24-h exposure tim e (data not shown) . Thus, the 
anti proliferative activity seems to correlate with th e PGs with a 
cyclopentane rin g containin g an a , {3-unsaturated keton e [23,24]. 
T hese PGs were also reported to inhibit biosyntheses of macro-
molecul es such as DNA, RNA, and protein in several lines of 
cultured cells [11 , 12] . Consistent w ith these reports, ~7-PGAl 
also considerably inhibited the DNA biosynthesis in PAM 212 
cells (Table II) . 
The actio n mechan ism of cytotoxicity of cyclopentenone PGs 
remains unknown at present. The postul ated ro le of cyclic-AMP 
as a mcdiator of PG-induced g rowth inhibition has been ques-
tioncd, because ~7_PGA I and ~1 2_PGJ 2 fa il to elevate the intra-
cullul ar cyclic-AMP level in PAM 212 cells, as illustrated in Table 
III. Although PGE was the potent stimulator of adenylate cyclase 
in th ese cells, PGE 1 was several times less potent than ~7-PGAI 
or ~I Z_PGJ2 in cell g rowth inhibition (Table I) . In o ur preliminary 
experim ent, antioxidants such as a-topopherol , coenzyme Q , and 
superoxide dismutase showed no effects on the inhibition of pro-
liferation of PAM 212 cells by ~7_PGAI ' Hu ghes-Ful ford et al 
[25) and Bhu yan et al [26] showed that the cyclopentenon e PGs 
exerted g rowth inhibition by arresting cells in G phase of the cell 
cycle. Furthermore, Narumiya and Fukushima demonstrated that 
the cyclopentenone PGs accumul ated in nucl ei and bo und to some 
nuclear components [27], sugges tin g that the PGs act directly on 
nuclei to express their g rowth inhibition. 
Prostaglandin O2 is o ne of the class ic PGs, form ing in a var iety 
of ti ssues, in cl udin g skin , and modulatin g their fun ction under 
various physiologic' and pathologic conditions [28]. Prostaglandin 
O 2 also shows signifi cant cytotoxic activity o n transformed epi-
dermal cell s as described above. T he PGD2 level in m ouse skin 
was signifi cantl y hi gher 3 and 6 h after UVB irradiation [8]. T hese 
res ults suggest that PGD2 might pla y an important role in the 
regulation of the proliferation of epidermal cells, at least in part , 
altho ugh the natural occurrence of cyclopentenone PGs has not 
been demonstrated yet. 
Prostaglandin Dz and ~ 12_PGJ2 have less ca tastrophic action on 
systemic circulation such as hypotension and arrhythmia than 
other PGs, particularl y PGE2, indi cating that hi gh doses can be 
adm inistered safety in vivo [29,30]. Furthermore, beca use PGD2 
and ~ 12_PGJ2 are not metabolized by N ADH-linked 15-hydroxy-
prostaglandin dehydrogenase, a maj o r PG m eta bolizing enzyme, 
w hich is abundant in var ious tissues [31], PGD2 or its derivatives 
may be promising and useful antineoplas tic agents. Recently, 
subcu taneous adminis tration of these PGs to human m elano m a 
cells [32] and ovaria n ca ncer cells [33] g rowing in ath ymi c nude 
mice caused signifi cant growth inhibition. In vivo experiments 
on human skin ca ncer are also in prog ress in our laboratory . 
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